Therapeutic Value and Regulatory Characteristics of Breakthrough Therapy Drugs in the USA and China (2021-2023): A Retrospective Cohort Study March 6, 2026
Pricing Trends and Overlapping Indications of Checkpoint Inhibitors for Cancer Treatment March 6, 2026
Patient and Population Impacts of Multigene Panel and Pembrolizumab Coverage in Metastatic Melanoma March 6, 2026
Optimizing Oncology Drug Development: Systematic Review of 22 Years of Myeloma Randomized Controlled Trials March 6, 2026